| Financial Year |
March 31 2023 |
| Monetary Funds |
2,863,680,485.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,321,171.32 |
| Accounts Receivable |
433,180,301.83 |
| Advances to Suppliers |
31,929,727.56 |
| Other Receivables |
23,641,153.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
59,228,184.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,552,921.83 |
| Total Current Assets |
3,465,182,107.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
9,632,305.21 |
| Long-term Equity Investment |
253,756,077.57 |
| Investment Properties |
-- |
| Fixed Assetes |
740,395,629.14 |
| Under-construction Projects |
131,192,095.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,051,263,321.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,221,043.98 |
| Deferred Income Tax Assets |
18,815,885.94 |
| Other Non-Current Assets |
10,356,523.59 |
| Sub-Total of Non-Current Assets |
15,452,262,876.16 |
| Total Assets |
18,917,444,983.77 |
| Short-Term Loans |
2,471,877,472.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,349,228.23 |
| Accounts Payable |
338,135,406.46 |
| Accounts Received In Advance |
22,554,111.29 |
| Employee Compensation Payable |
23,432,296.10 |
| Taxes Payable |
104,308,042.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
110,484,226.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
546,811,456.67 |
| Other Current Liabilities |
601,220,229.02 |
| Sub-Total of Current Liabilities |
4,261,542,328.94 |
| Long-term Loans |
4,645,100,000.00 |
| Bonds Payable |
503,092,507.22 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
110,370.51 |
| Deferred Income Tax Liabilities |
11,859,171.57 |
| Other Non-Current Liabilities |
59,200,000.00 |
| Sub-Total of Non-Current Liabilities |
5,845,319,459.89 |
| Total Liabilities |
10,106,861,788.83 |
| Paid-In Capital(Or Share Stock) |
1,610,115,901.00 |
| Capital Surplus |
1,107,002,873.36 |
| Surplus Reserve |
1,457,523,506.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,659,371,944.40 |
| Minority Stockholder's Interest |
964,253,159.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,846,330,035.10 |
| Owner's Equity（Stockholder's Equity） |
8,810,583,194.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,917,444,983.77 |
